It’s the news the many feared: early data shows the Oxford-AstraZeneca vaccine may provide only “minimal protection” against mild to moderate illness caused by the coronavirus variant first identified in South Africa.
Why bad news for AstraZeneca’s vaccine is a roadblock on the way out of the pandemic